Filing Flows › Autolus Therapeutics (AUTL) › Recalls, complaints & regulation
Autolus Therapeutics (AUTL): clinical trials
Autolus Therapeutics (AUTL) beyond its filings: 6 active clinical trials.
Autolus Therapeutics' latest quarter
Autolus Therapeutics, Q2 2026: revenue $45.7M (+118% year over year), operating margin -95.9%, net loss $39.1M, operating cash flow −$25.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Autolus Therapeutics have?
6 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.